Risperidone for the Treatment of Cocaine Dependence - 7
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000342
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Pemoline in the Treatment of Stimulant Dependence - 5
Phase 2
Withdrawn
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000340
Tyrosine for Methamphetamine Dependence - 1
Phase 2
Completed
- Conditions
- Amphetamine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 89
- Registration Number
- NCT00000322
- Locations
- ๐บ๐ธ
Haight Ashbury Free Clinics, San Francisco, California, United States
Effects of Labetalol on Human Cocaine Use - 8
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000291
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Pharmacological Modulation of Cocaine Effects - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000201
- Locations
- ๐บ๐ธ
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States
Stress Hormones and Human Cocaine Use - 7
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000290
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Phase 2
Completed
- Conditions
- Alcohol-Related DisordersCocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000307
- Locations
- ๐บ๐ธ
University of Texas Health Science Center, Houston, Texas, United States
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Phase 1
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000354
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Relapse Patterns in Female Cocaine Users - 4
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000287
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 200
- Registration Number
- NCT00000324
- Locations
- ๐บ๐ธ
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath